A detailed history of Spears Abacus Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 223,810 shares of ABBV stock, worth $39.3 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
223,810
Previous 270,388 17.23%
Holding current value
$39.3 Million
Previous $46.4 Million 4.7%
% of portfolio
0.93%
Previous 1.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $7.63 Million - $9.28 Million
-46,578 Reduced 17.23%
223,810 $44.2 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $253,081 - $295,542
-1,635 Reduced 0.6%
270,388 $46.4 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $42.3 Million - $48.2 Million
264,906 Added 3722.16%
272,023 $49.5 Million
Q3 2023

Nov 21, 2023

BUY
$133.59 - $154.65 $2,271 - $2,629
17 Added 0.24%
7,117 $1.06 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $51,546 - $64,146
-389 Reduced 5.19%
7,100 $956,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $14,316 - $16,487
99 Added 1.34%
7,489 $1.19 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $6,915 - $8,293
50 Added 0.68%
7,390 $1.2 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $985,101 - $1.13 Million
7,340 New
7,340 $985,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $60,710 - $75,325
-460 Reduced 5.9%
7,340 $1.19 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $40,926 - $45,594
389 Added 5.25%
7,800 $879,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $576,542 - $676,670
-6,711 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $4,035 - $5,399
55 Added 0.83%
6,711 $659,000
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $6,579 - $9,974
-102 Reduced 1.51%
6,656 $507,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $7,357 - $9,205
102 Added 1.53%
6,758 $598,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $227,105 - $273,046
-3,606 Reduced 35.14%
6,656 $504,000
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $466,864 - $596,761
7,106 Added 225.16%
10,262 $746,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $5,373 - $5,892
-60 Reduced 1.87%
3,156 $305,000
Q2 2017

Aug 11, 2017

BUY
N/A
3,216
3,216 $233,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.